Aspire Biopharma Holdings Inc (ASBP)

$0.05 -0.03 (-32.83%)
Market Cap 10.21M
Revenue (ttm) 0.00
Net Income (ttm) -12.54M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.54
Volume 54,915,318
Avg Vol 49,473,844
Day's Range N/A - N/A
Shares Out 107.48M
Stochastic %K 5%
Beta 0.81
Analysts Strong Buy
Price Target N/A

Company Profile

Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers Instaprin, a sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, including a melatonin sleep-aid product; vitamins D, E, and K; testos...

Industry: Biotechnology
Sector: Healthcare
Phone: 415 592 7399
Address:
23150 Fashion Drive, Suite 232, Estero, United States
Arnie_510
Arnie_510 Jan. 14 at 6:10 PM
$ASBP At my cost average either way I win.
0 · Reply
Bookshelf1974
Bookshelf1974 Jan. 14 at 6:08 PM
$ASBP the director who resigned November 7th, had/has 11 million shares. More then the current interim CEO.
0 · Reply
Golden_horse
Golden_horse Jan. 14 at 6:07 PM
$ASBP : anyone have contact info for the CEO ????? . PCG Advisory Kevin McGrath +1-646-418-7002 is MISSING IN ACTION!!! Most probably has fled the battle field…
0 · Reply
sullivan1
sullivan1 Jan. 14 at 6:05 PM
$IVP Today announced a reverse stock split of its issued and outstanding common stock, par value $0.01 per share, at a ratio of one (1) share of common stock for every forty (40) shares of common stock, that will become effective as of 12:01 a.m. (Eastern Time) on January 16, 2026 (the "Effective Date"). $ASBP
1 · Reply
Arnie_510
Arnie_510 Jan. 14 at 6:01 PM
$ASBP OT: Poor Howard can barely afford a decent T-shirt these days. His dreams of being a big league player are over.
1 · Reply
NatureBoyRonFlair
NatureBoyRonFlair Jan. 14 at 5:51 PM
$ASBP on investing They said, direction bought stock aggressively I don't know date exactly but they did
1 · Reply
stockktwats
stockktwats Jan. 14 at 5:42 PM
$ASBP can someone explain my math and see what I’m doing wrong? After the split 50,000 shares becomes 1250 shares and if the stock goes to $25, you only make $31,250 instead of 1.25 million? This is just a hypothetical situation. This is not my position nor is it my delusion that I will become a millionaire on the stock. I am just asking a generic question.
6 · Reply
Jmk1985
Jmk1985 Jan. 14 at 5:31 PM
$ASBP making my money back slowly in $SAFX I hope $ASBP gets delisted 😀
1 · Reply
NatureBoyRonFlair
NatureBoyRonFlair Jan. 14 at 5:27 PM
$ASBP do you smell what asbp is Cookn
2 · Reply
Arnie_510
Arnie_510 Jan. 14 at 5:26 PM
$ASBP Most of you get shaken out today. Those buying your shares win. Not counting short covering.
0 · Reply
Latest News on ASBP
Aspire Biopharma Announces Successful Pre-IND Meeting with FDA for High-Dose Sublingual Aspirin (OTASA)

Jan 7, 2026, 8:00 AM EST - 7 days ago

Aspire Biopharma Announces Successful Pre-IND Meeting with FDA for High-Dose Sublingual Aspirin (OTASA)

Aspire Biopharma Welcomes Elite Ultra-Runner Ashley Paulson as Global Brand Ambassador for BUZZ BOMB(R) Caffeine

Dec 18, 2025, 8:30 AM EST - 27 days ago

Aspire Biopharma Welcomes Elite Ultra-Runner Ashley Paulson as Global Brand Ambassador for BUZZ BOMB(R) Caffeine

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

Dec 12, 2025, 5:00 PM EST - 4 weeks ago

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

Aspire Biopharma Provides Q3 2025 Business Update

Dec 4, 2025, 9:00 AM EST - 5 weeks ago

Aspire Biopharma Provides Q3 2025 Business Update

Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)

Dec 2, 2025, 9:00 AM EST - 6 weeks ago

Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)

Aspire BioPharma Welcomes Dr. Mark J. Jaroszeski as New Scientific Team Member

Nov 26, 2025, 9:00 AM EST - 7 weeks ago

Aspire BioPharma Welcomes Dr. Mark J. Jaroszeski as New Scientific Team Member

Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin

Nov 6, 2025, 9:00 AM EST - 2 months ago

Aspire Biopharma Engages with Global Pharmaceutical Leaders at CPHI Frankfurt to Advance Partnership Discussions for its Sublingual High-Dose Aspirin

Aspire Biopharma Holdings, Inc. Announces Filing of Omnibus Patent Application for Its Innovative Sublingual Drug Delivery Platform

Oct 6, 2025, 8:30 AM EDT - 3 months ago

Aspire Biopharma Holdings, Inc. Announces Filing of Omnibus Patent Application for Its Innovative Sublingual Drug Delivery Platform

Aspire Biopharma to Present at Noble Capital Markets 2025 Emerging Growth Virtual Equity Conference - October 8-9, 2025

Oct 3, 2025, 11:30 AM EDT - 3 months ago

Aspire Biopharma to Present at Noble Capital Markets 2025 Emerging Growth Virtual Equity Conference - October 8-9, 2025

Crude Oil Down 2%; Aspire Biopharma Shares Spike Higher

Oct 2, 2025, 2:44 PM EDT - 3 months ago

Crude Oil Down 2%; Aspire Biopharma Shares Spike Higher

Aspire Biopharma Announces Milestone Roadmap Targeting H2 2025 FDA Submission for Sublingual Aspirin and Key 2026 Milestones for Needle-Free Semaglutide (Diabetes, Weight Management) and more-rapid ED medication

Oct 1, 2025, 8:30 AM EDT - 3 months ago

Aspire Biopharma Announces Milestone Roadmap Targeting H2 2025 FDA Submission for Sublingual Aspirin and Key 2026 Milestones for Needle-Free Semaglutide (Diabetes, Weight Management) and more-rapid ED medication

Aspire Biopharma Engages Well-Known Athletes and Influencers to Accelerate Consumer Awareness and Sales of its BUZZ BOMB(TM) Sublingual Caffeine Pre-Workout Product

Sep 17, 2025, 8:30 AM EDT - 4 months ago

Aspire Biopharma Engages Well-Known Athletes and Influencers to Accelerate Consumer Awareness and Sales of its BUZZ BOMB(TM) Sublingual Caffeine Pre-Workout Product

Aspire Biopharma Announces Initial Production Order of Two Million Servings (100,000 20-packs) of BUZZ BOMB(TM) Pre-Workout Supplement

Sep 16, 2025, 8:30 AM EDT - 4 months ago

Aspire Biopharma Announces Initial Production Order of Two Million Servings (100,000 20-packs) of BUZZ BOMB(TM) Pre-Workout Supplement

Aspire Biopharma Announces Breakthrough Final Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)

Sep 3, 2025, 8:30 AM EDT - 4 months ago

Aspire Biopharma Announces Breakthrough Final Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)

Aspire Biopharma Announces Positive Top-Line Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)

Aug 18, 2025, 8:30 AM EDT - 5 months ago

Aspire Biopharma Announces Positive Top-Line Results from Clinical Trial of Investigational New Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20

Aug 14, 2025, 8:00 AM EDT - 5 months ago

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 20

Aspire Biopharma Successfully Launches BUZZ BOMB(TM) Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World

Aug 13, 2025, 9:10 AM EDT - 5 months ago

Aspire Biopharma Successfully Launches BUZZ BOMB(TM) Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World

Aspire Biopharma Holdings, Inc. Unveils E-commerce Platform, Launches with its BUZZ BOMB Pre-Workout Supplement

Jul 31, 2025, 8:30 AM EDT - 5 months ago

Aspire Biopharma Holdings, Inc. Unveils E-commerce Platform, Launches with its BUZZ BOMB Pre-Workout Supplement

Aspire Biopharma Holdings, Inc. Announces CEO Transition

Jul 30, 2025, 7:45 PM EDT - 5 months ago

Aspire Biopharma Holdings, Inc. Announces CEO Transition

Aspire Biopharma Holdings, Inc. to Launch its BUZZ BOMB Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World

Jul 22, 2025, 10:45 AM EDT - 6 months ago

Aspire Biopharma Holdings, Inc. to Launch its BUZZ BOMB Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World

Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement

Jul 9, 2025, 8:30 AM EDT - 6 months ago

Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement

Aspire Biopharma Holdings, Inc., Announces Last Patient Dosed in Phase 1 Clinical Trial of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

Jun 24, 2025, 8:30 AM EDT - 7 months ago

Aspire Biopharma Holdings, Inc., Announces Last Patient Dosed in Phase 1 Clinical Trial of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

Aspire Biopharma Holdings, Inc., Announces Michael C. Howe - With Decades of Experience at Leading and Building Brands in the Healthcare and Consumer Space - To Be Its New Chief Executive Officer

Jun 10, 2025, 8:30 AM EDT - 7 months ago

Aspire Biopharma Holdings, Inc., Announces Michael C. Howe - With Decades of Experience at Leading and Building Brands in the Healthcare and Consumer Space - To Be Its New Chief Executive Officer

Aspire Biopharma Holdings, Inc., Provides Development Update on BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement, Expected to Launch in Third Quarter of 2025

May 28, 2025, 8:30 AM EDT - 8 months ago

Aspire Biopharma Holdings, Inc., Provides Development Update on BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement, Expected to Launch in Third Quarter of 2025

Aspire Biopharma Holdings, Inc., Announces First Patient Dosed in Phase 1 Clinical Trial for its Lead Program, an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

May 20, 2025, 8:30 AM EDT - 8 months ago

Aspire Biopharma Holdings, Inc., Announces First Patient Dosed in Phase 1 Clinical Trial for its Lead Program, an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference May 21

May 8, 2025, 8:00 AM EDT - 8 months ago

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference May 21

Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

Apr 29, 2025, 8:30 AM EDT - 9 months ago

Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17

Apr 14, 2025, 8:30 AM EDT - 9 months ago

Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17

Aspire Biopharma Holdings, Inc., Commences Initial Production of its Pre-Workout Performance Supplement

Apr 11, 2025, 8:30 AM EDT - 9 months ago

Aspire Biopharma Holdings, Inc., Commences Initial Production of its Pre-Workout Performance Supplement

Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

Apr 9, 2025, 8:30 AM EDT - 10 months ago

Aspire Biopharma Holdings, Inc., Announces Phase 1 Clinical Trial Initiation of its Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation

Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice (“GMP”) Clinical Batch of Pharmaceutical Grade Oral Mucosal Fast Acting Formulation of Aspirin

Mar 20, 2025, 8:30 AM EDT - 10 months ago

Aspire Biopharma Holdings, Inc., Contract Manufacturer, Glatt Air Techniques, Inc., has Completed Its First Good Manufacturing Practice (“GMP”) Clinical Batch of Pharmaceutical Grade Oral Mucosal Fast Acting Formulation of Aspirin

Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform

Mar 13, 2025, 8:30 AM EDT - 10 months ago

Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform

An Interview with the CEO: How Aspire Biopharma is Disrupting a $100 Billion Market with Sublingual Innovation

Mar 11, 2025, 8:00 AM EDT - 11 months ago

An Interview with the CEO: How Aspire Biopharma is Disrupting a $100 Billion Market with Sublingual Innovation

Aspire Biopharma Holdings, Inc., to Launch the Next Generation of Pre-Workout Performance Supplement

Mar 3, 2025, 7:30 AM EST - 11 months ago

Aspire Biopharma Holdings, Inc., to Launch the Next Generation of Pre-Workout Performance Supplement

Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin

Feb 25, 2025, 7:30 AM EST - 11 months ago

Aspire Biopharma Holdings, Inc., Provides an Update on Lead Product Candidate: High-Dose, Sublingual Aspirin

Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement

Feb 20, 2025, 6:15 PM EST - 11 months ago

Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement

Arnie_510
Arnie_510 Jan. 14 at 6:10 PM
$ASBP At my cost average either way I win.
0 · Reply
Bookshelf1974
Bookshelf1974 Jan. 14 at 6:08 PM
$ASBP the director who resigned November 7th, had/has 11 million shares. More then the current interim CEO.
0 · Reply
Golden_horse
Golden_horse Jan. 14 at 6:07 PM
$ASBP : anyone have contact info for the CEO ????? . PCG Advisory Kevin McGrath +1-646-418-7002 is MISSING IN ACTION!!! Most probably has fled the battle field…
0 · Reply
sullivan1
sullivan1 Jan. 14 at 6:05 PM
$IVP Today announced a reverse stock split of its issued and outstanding common stock, par value $0.01 per share, at a ratio of one (1) share of common stock for every forty (40) shares of common stock, that will become effective as of 12:01 a.m. (Eastern Time) on January 16, 2026 (the "Effective Date"). $ASBP
1 · Reply
Arnie_510
Arnie_510 Jan. 14 at 6:01 PM
$ASBP OT: Poor Howard can barely afford a decent T-shirt these days. His dreams of being a big league player are over.
1 · Reply
NatureBoyRonFlair
NatureBoyRonFlair Jan. 14 at 5:51 PM
$ASBP on investing They said, direction bought stock aggressively I don't know date exactly but they did
1 · Reply
stockktwats
stockktwats Jan. 14 at 5:42 PM
$ASBP can someone explain my math and see what I’m doing wrong? After the split 50,000 shares becomes 1250 shares and if the stock goes to $25, you only make $31,250 instead of 1.25 million? This is just a hypothetical situation. This is not my position nor is it my delusion that I will become a millionaire on the stock. I am just asking a generic question.
6 · Reply
Jmk1985
Jmk1985 Jan. 14 at 5:31 PM
$ASBP making my money back slowly in $SAFX I hope $ASBP gets delisted 😀
1 · Reply
NatureBoyRonFlair
NatureBoyRonFlair Jan. 14 at 5:27 PM
$ASBP do you smell what asbp is Cookn
2 · Reply
Arnie_510
Arnie_510 Jan. 14 at 5:26 PM
$ASBP Most of you get shaken out today. Those buying your shares win. Not counting short covering.
0 · Reply
edikan
edikan Jan. 14 at 5:26 PM
$ASBP 😂😂😂😂 When will people learn to separate emotions from business?
1 · Reply
Phantom_Dancer
Phantom_Dancer Jan. 14 at 5:18 PM
$ASBP R/S called it. Should’ve sold in pre-market or market open on January 7 for decent 50-80% gains instead of bagholding hoping for a 10x runner. Now that it has dropped this much could be a good time to get back In because CEO will need to pump this stock to get his return investment and keep the shorts off his back.
1 · Reply
UgoGreg
UgoGreg Jan. 14 at 5:17 PM
$ASBP https://youtu.be/ygBN8MilTyc
0 · Reply
Arnie_510
Arnie_510 Jan. 14 at 5:13 PM
$ASBP If it splits in this price range then that means a buyout deal has been agreed upon. Otherwise, it rallies to 0.13 or higher prior to the 16th. They are not going to want a sub $5 stock price. This is all being orchestrated, right down to the short activity. NFA
0 · Reply
UgoGreg
UgoGreg Jan. 14 at 5:11 PM
$ASBP https://youtu.be/z_sivgG6Cyg
0 · Reply
Skamiller
Skamiller Jan. 14 at 5:11 PM
$ASBP glad i only bought like $150 worth of this one
2 · Reply
modrica3
modrica3 Jan. 14 at 5:05 PM
$ASBP by looking at last 10q and considering cash burn there seems to be enough cash/ funds for q1 so basically by april they will need more money so yea possibility of offering and dilution soon is real gl
1 · Reply
todayatatime
todayatatime Jan. 14 at 4:59 PM
$ASBP if it drops below 5c again it could be the end of asbp. hopefully working up to 6c will be a good floor post RS. wild we lost nearly 50% just on news of split.
0 · Reply
Arnie_510
Arnie_510 Jan. 14 at 4:52 PM
$ASBP So both the dealer and player are showing a 6 card. You, have bet $50K What’s your move? I know mine.
1 · Reply
Psikus
Psikus Jan. 14 at 4:52 PM
$ASBP Seriously guys, have you seen that dude Lifeluxury or something like that? I did not read his posts right after he posted $200 price target but I know he pumped the shit out of this stock, not sure if he blocked me because I asked some questions or still here. I wonder if his account is still here. What was his name in here?
1 · Reply
Emperor_Zurg
Emperor_Zurg Jan. 14 at 4:47 PM
$ASBP The saving grace is that it will be a relatively low float after split. TGL and MIGI popped within a week afterwards, though they were different situations. Anyone know the potential for dilution after the split?
0 · Reply
Golden_horse
Golden_horse Jan. 14 at 4:43 PM
$ASBP
0 · Reply